Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results
从非聚乙二醇化干扰素β-1a过渡到聚乙二醇化干扰素β-1a的患者出现新的流感样症状的风险较低:ALLOW 3b期试验结果
期刊:Multiple Sclerosis Journal - Experimental, Translational and Clinical
影响因子:2.3
doi:10.1177/2055217318822148
Naismith, Robert T; Hendin, Barry; Wray, Sibyl; Huang, DeRen; Gaudenzi, Fiorenza; Dong, Qunming; Sperling, Bjørn; Mann, Monica; Werneburg, Brian